Literature DB >> 16487244

Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque.

M Karaduman1, C Oktenli, U Musabak, A Sengul, Z Yesilova, F Cingoz, A Olgun, S Y Sanisoglu, O Baysan, O Yildiz, A Taslipinar, H Tatar, M Kutlu, M Ozata.   

Abstract

The aim of the present study was to explore the relationship between tissue levels of leptin, soluble interleukin-6 receptor (sIL-6R), high-sensitive-C-reactive protein (hs-CRP) and soluble vascular cell adhesion molecule-1 (sVCAM-1) in atherosclerotic plaques, and traditional risk factors. Coronary artery specimens were obtained from 35 consecutive patients (26 men and nine women) who underwent coronary artery bypass grafting procedure. The mean tissue levels of leptin, hs-CRP and sIL-6R were significantly higher in patients with diabetes mellitus than without diabetes mellitus. When patients were classified according to the smoking status, the mean tissue levels of leptin, hs-CRP and sIL-6R were significantly higher in current smokers than both former smokers and non-smokers. In addition, the mean tissue levels of leptin and sIL-6R were significantly higher in former smokers than non-smokers. There was a positive association between leptin and hs-CRP, sIL-6R and plasma glucose in all patients. Plasma HDL levels were associated negatively with atherosclerotic tissue levels of leptin. Tissue levels of sIL-6R were associated significantly in a positive manner with leptin, hs-CRP and plasma glucose, while tissue levels of hs-CRP were associated with both leptin and sIL-6R. In conclusion, it is attractive to speculate that hs-CRP, sIL-6R and leptin could act synergistically in course of local inflammatory activity and those molecules may not be just markers of inflammation and cardiovascular risk but are also likely to play a pathogenic role in atheromatous plaque. In addition, atherosclerotic tissue levels of CRP, sIL-6R and leptin were significantly higher in current smokers and patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487244      PMCID: PMC1809610          DOI: 10.1111/j.1365-2249.2006.03025.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  40 in total

1.  High levels of circulating proinflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease.

Authors:  J S Yudkin; C S Yajnik; V Mohamed-Ali; K Bulmer
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

2.  Human leptin stimulates proliferation and activation of human circulating monocytes.

Authors:  J Santos-Alvarez; R Goberna; V Sánchez-Margalet
Journal:  Cell Immunol       Date:  1999-05-25       Impact factor: 4.868

3.  Leptin induces oxidative stress in human endothelial cells.

Authors:  A Bouloumie; T Marumo; M Lafontan; R Busse
Journal:  FASEB J       Date:  1999-07       Impact factor: 5.191

4.  Associations of obesity markers, insulin, and sex hormones with HDL-cholesterol levels in Turkish and German individuals.

Authors:  G Hergenç; H Schulte; G Assmann; A von Eckardstein
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

5.  Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.

Authors:  S Kado; T Nagase; N Nagata
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

6.  Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

Authors:  R De Caterina; G Basta; G Lazzerini; G Dell'Omo; R Petrucci; M Morale; F Carmassi; R Pedrinelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

7.  Interleukin 1 alpha increases serum leptin concentrations in humans.

Authors:  J E Janik; B D Curti; R V Considine; H C Rager; G C Powers; W G Alvord; J W Smith; B L Gause; W C Kopp
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

8.  Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall.

Authors:  H G Rus; R Vlaicu; F Niculescu
Journal:  Atherosclerosis       Date:  1996-12-20       Impact factor: 5.162

9.  Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markers.

Authors:  M P de Maat; A Pietersma; M Kofflard; W Sluiter; C Kluft
Journal:  Atherosclerosis       Date:  1996-04-05       Impact factor: 5.162

10.  C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

Authors:  S A Jones; D Novick; S Horiuchi; N Yamamoto; A J Szalai; G M Fuller
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more
  6 in total

1.  The change of serum leptin and its relationship with platelet membrane glycoprotein Ib in patients with coronary heart disease.

Authors:  Dasheng Xia; Yanqiu Song; Chao Li; Feng Zhang; Minxin Wei
Journal:  Front Med China       Date:  2007-10

2.  High habitual dietary alpha-linolenic acid intake is associated with decreased plasma soluble interleukin-6 receptor concentrations in male twins.

Authors:  Jun Dai; Thomas R Ziegler; Roberd M Bostick; Amita K Manatunga; Dean P Jones; Jack Goldberg; Andrew Miller; Gerald Vogt; Peter W Wilson; Linda Jones; Lucy Shallenberger; Viola Vaccarino
Journal:  Am J Clin Nutr       Date:  2010-05-12       Impact factor: 7.045

Review 3.  Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases.

Authors:  Morena Scotece; Javier Conde; Rodolfo Gómez; Verónica López; Jesús Pino; Antonio González; Francisca Lago; Juan J Gómez-Reino; Oreste Gualillo
Journal:  Mediators Inflamm       Date:  2012-07-15       Impact factor: 4.711

4.  Assessment of serum leptin, pregnancy-associated plasma protein A and CRP levels as indicators of plaque vulnerability in patients with acute coronary syndrome.

Authors:  Moushumi Lodh; Binita Goswami; Ashok Parida; Surajeet Patra; Alpana Saxena
Journal:  Cardiovasc J Afr       Date:  2012-07       Impact factor: 1.167

5.  A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions.

Authors:  Marielle Kaplan; Shadi Hamoud; Yevgeny Tendler; Edna Meilin; Aviva Lazarovitch; Samy Nitecki; Tony Hayek
Journal:  J Inflamm (Lond)       Date:  2014-03-03       Impact factor: 4.981

6.  Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.

Authors:  Surya Prakash Bhatt; Randeep Guleria; Naval K Vikram; S Vivekanandhan; Yogendra Singh; A K Gupta
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.